169 related articles for article (PubMed ID: 37244257)
1. A new paradigm in transplant immunology: At the crossroad of synthetic biology and biomaterials.
Zhang ZJ; Ding LY; Zuo XL; Feng H; Xia Q
Med; 2023 Jul; 4(7):404-431. PubMed ID: 37244257
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of recipients of both bone marrow and solid organ transplants. A review.
Dey B; Sykes M; Spitzer TR
Medicine (Baltimore); 1998 Sep; 77(5):355-69. PubMed ID: 9772924
[TBL] [Abstract][Full Text] [Related]
3. Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review.
Rezahosseini O; Møller DL; Knudsen AD; Sørensen SS; Perch M; Gustafsson F; Rasmussen A; Ostrowski SR; Nielsen SD
Front Immunol; 2020; 11():567715. PubMed ID: 33178194
[No Abstract] [Full Text] [Related]
4. Immunosuppression regimens to address alloantibodies in transplant recipients.
Everly MJ
Clin Transpl; 2012; ():219-23. PubMed ID: 23721025
[TBL] [Abstract][Full Text] [Related]
5. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial.
Drabe CH; Sørensen SS; Rasmussen A; Perch M; Gustafsson F; Rezahosseini O; Lundgren JD; Ostrowski SR; Nielsen SD
BMC Infect Dis; 2019 Jul; 19(1):573. PubMed ID: 31269923
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic issues of antiretroviral agents and immunosuppressive regimens in HIV-infected solid organ transplant recipients.
Primeggia J; Timpone JG; Kumar PN
Infect Dis Clin North Am; 2013 Jun; 27(2):473-86. PubMed ID: 23714350
[TBL] [Abstract][Full Text] [Related]
7. Infections in solid organ transplant HIV-infected patients.
Miro JM; Agüero F; Duclos-Vallée JC; Mueller NJ; Grossi P; Moreno A;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():119-30. PubMed ID: 25040016
[TBL] [Abstract][Full Text] [Related]
8. Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine.
Cai J; Wu G; Qing A; Everly M; Cheng E; Terasaki P
Clin Transpl; 2014; ():33-47. PubMed ID: 26281125
[TBL] [Abstract][Full Text] [Related]
9. The gut microbiome in solid organ transplantation.
Baghai Arassi M; Zeller G; Karcher N; Zimmermann M; Toenshoff B
Pediatr Transplant; 2020 Nov; 24(7):e13866. PubMed ID: 32997434
[TBL] [Abstract][Full Text] [Related]
10. Treatment and outcomes of immune cytopenias following solid organ transplant in children.
Schoettler M; Elisofon SA; Kim HB; Blume ED; Rodig N; Boyer D; Neufeld EJ; Grace RF
Pediatr Blood Cancer; 2015 Feb; 62(2):214-218. PubMed ID: 25308853
[TBL] [Abstract][Full Text] [Related]
11. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.
Abdel-Wahab N; Safa H; Abudayyeh A; Johnson DH; Trinh VA; Zobniw CM; Lin H; Wong MK; Abdelrahim M; Gaber AO; Suarez-Almazor ME; Diab A
J Immunother Cancer; 2019 Apr; 7(1):106. PubMed ID: 30992053
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.
Chong PP; Avery RK
Clin Ther; 2017 Aug; 39(8):1581-1598. PubMed ID: 28751095
[TBL] [Abstract][Full Text] [Related]
13. Sepsis outcomes in solid organ transplant recipients.
Gotur DB; Masud FN; Ezeana CF; Nisar T; Paranilam J; Chen S; Puppala M; Wong STC; Zimmerman JL
Transpl Infect Dis; 2020 Feb; 22(1):e13214. PubMed ID: 31755202
[TBL] [Abstract][Full Text] [Related]
14. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
[TBL] [Abstract][Full Text] [Related]
15. Perioperative antibiotic stewardship in the organ transplant setting.
Graziano E; Peghin M; Grossi PA
Transpl Infect Dis; 2022 Oct; 24(5):e13895. PubMed ID: 35781915
[TBL] [Abstract][Full Text] [Related]
16. Everolimus-based immunosuppressive regimens in lung transplant recipients: impact on CMV infection.
Rittà M; Costa C; Solidoro P; Sidoti F; Libertucci D; Boffini M; Rinaldi M; Baldi S; Cavallo R
Antiviral Res; 2015 Jan; 113():19-26. PubMed ID: 25446337
[TBL] [Abstract][Full Text] [Related]
17. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
18. The living interface between synthetic biology and biomaterial design.
Liu AP; Appel EA; Ashby PD; Baker BM; Franco E; Gu L; Haynes K; Joshi NS; Kloxin AM; Kouwer PHJ; Mittal J; Morsut L; Noireaux V; Parekh S; Schulman R; Tang SKY; Valentine MT; Vega SL; Weber W; Stephanopoulos N; Chaudhuri O
Nat Mater; 2022 Apr; 21(4):390-397. PubMed ID: 35361951
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis.
Hansrivijit P; Trongtorsak A; Puthenpura MM; Boonpheng B; Thongprayoon C; Wijarnpreecha K; Choudhury A; Kaewput W; Mao SA; Mao MA; Jadlowiec CC; Cheungpasitporn W
World J Gastroenterol; 2021 Mar; 27(12):1240-1254. PubMed ID: 33828397
[TBL] [Abstract][Full Text] [Related]
20. Treating tuberculosis in solid organ transplant recipients.
Sun HY
Curr Opin Infect Dis; 2014 Dec; 27(6):501-5. PubMed ID: 25211360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
